A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...
However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...
Being physically active is good for every part of you—including your brain. The latest research shows that it can help slow ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results